Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseases

Patients with inflammatory rheumatic diseases (IRD) are at increased risk for worse COVID-19 outcomes. Identifying whether mRNA vaccines differ in immunogenicity and examining the effects of immunomodulatory treatments may support COVID-19 vaccination strategies. We aimed to conduct a long-term, mod...

Descripción completa

Detalles Bibliográficos
Autores principales: Raptis, Catherine E., Berger, Christoph T., Ciurea, Adrian, Andrey, Diego O., Polysopoulos, Christos, Lescuyer, Pierre, Maletic, Tanja, Riek, Myriam, Scherer, Almut, von Loga, Isabell, Safford, Judith, Lauper, Kim, Möller, Burkhard, Vuilleumier, Nicolas, Finckh, Axel, Rubbert-Roth, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606233/
https://www.ncbi.nlm.nih.gov/pubmed/36311791
http://dx.doi.org/10.3389/fimmu.2022.1016927

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606233/
https://www.ncbi.nlm.nih.gov/pubmed/36311791
http://dx.doi.org/10.3389/fimmu.2022.1016927

Ejemplares similares